PDUFA Dates: February 2027

1 FDA target action date in February 2027. Each PDUFA date is the FDA's deadline to complete review of a drug application.

A single FDA target action date this month — Zipalertinib from Cullinan Therapeutics, Inc for NSCLC with EGFR exon 20 insertion (post-platinum).